Intestinal absorption and biliary elimination of glycyrrhizic acid diethyl ester in rats

被引:7
作者
Koga, Kenjiro [1 ]
Kawamura, Mayuri [1 ]
Iwase, Hiroshi [2 ]
Yoshikawa, Nobuji [3 ]
机构
[1] Hokuriku Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Kanazawa, Ishikawa 92011, Japan
[2] Cokey Syst Co Ltd, Div Res, Matsusaka, Japan
[3] Cokey Syst Co Ltd, Div Res & Dev, Matsusaka, Japan
来源
DRUG DESIGN DEVELOPMENT AND THERAPY | 2013年 / 7卷
关键词
glycyrrhizic acid; prodrug; intestinal absorption; bile elimination; pharmacokinetics; rat; HEPATITIS-C; DISPOSITION; EXCRETION;
D O I
10.2147/DDDT.S51638
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: The purpose of this study was to evaluate absorption and elimination from the gastrointestinal tract of glycyrrhizic acid diethyl ester (GZ-DE) which was prepared as a prodrug of glycyrrhizic acid (a poorly absorbed compound) in rats. Methods: After the GZ-DE solution was administered via the intravenous, intraduodenal, intraileal, and stomach routes, GZ-DE and GZ concentrations in bile were determined by high-performance liquid chromatography. The stability of GZ-DE was estimated from residual GZ-DE and GZ produced in GZ-DE solutions prepared with distilled water, a pH 1.2 solution, 0.9% NaCl solution, and phosphate-buffered solution (pH 7.4) at 37 degrees C. Results: GZ-DE was eliminated into bile by the pharmacokinetic parameters of apparent distribution rate constant (4.56 +/- 0.36 per hour) and apparent elimination rate constant (0.245 +/- 0.042 per hour). After intravenous and intraduodenal administration of GZ-DE, the concentration ratio of GZ-DE to GZ in bile was approximately 4:1, and the bioavailability of GZ containing GZ-DE was three-fold higher compared with the bioavailability of GZ after intraduodenal administration. GZ-DE was immediately precipitated in pH 1.2 solution and was converted to GZ by hydrolysis in pH 7.4 solution. Conclusion: Improvement of intestinal absorption of GZ was made possible by administration of GZ-DE into the intestine where absorption of GZ is lower than in the strong acidic environment of the stomach. However, because the elimination rate in bile simulated from kinetic parameters of GZ-DE was higher than the conversion rate from GZ-DE to GZ by hydrolysis, it is thought that the availability of GZ as a revolutionary prodrug was not high from the viewpoint of bioavailability of GZ in the liver by intestinal administration of GZ-DE.
引用
收藏
页码:1235 / 1243
页数:9
相关论文
共 18 条
  • [1] Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin-A Multicenter Study
    Acharya, Subrat K.
    Sreenivas, V.
    Gupta, Siddharth Datta
    Kumar, Shakti
    Chawla, Yogesh K.
    Tandon, Anurag
    Habeeb, Aejaz
    Kar, Premashish
    Chowdhury, Abhijit
    Choudhuri, Gourdas
    Sarin, Shiv K.
    Amarapurkar, D. N.
    Arankalle, Vidya
    Gupte, Mohan D.
    Gupta, Sushma
    Mukherjee, Deepali
    Seth, Divya
    Goyal, Rohit
    Tandon, Badri N.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (01) : 10 - 18
  • [2] Glycyrrhizin as antiviral agent against Hepatitis C Virus
    Ashfaq, Usman A.
    Masoud, Muhammad S.
    Nawaz, Zafar
    Riazuddin, Sheikh
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [3] Horikawa Masato, 2002, Drug Metab Pharmacokinet, V17, P23, DOI 10.2133/dmpk.17.23
  • [4] BILIARY-EXCRETION AND ENTEROHEPATIC CYCLING OF GLYCYRRHIZIN IN RATS
    ICHIKAWA, T
    ISHIDA, S
    SAKIYA, Y
    SAWADA, Y
    HANANO, M
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (07) : 672 - 675
  • [5] Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon-resistant active chronic hepatitis C
    Ikeda, Kenji
    [J]. HEPATOLOGY RESEARCH, 2007, 37 : S287 - S293
  • [6] Hydrolysis by carboxylesterase and disposition of prodrug with ester moiety
    Imai, Teruko
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (04): : 611 - 619
  • [7] ISHIDA S, 1990, CHEM PHARM BULL, V38, P212
  • [8] Preparation and rectal absorption of highly concentrated glycyrrhizin solution
    Koga, K
    Kawashima, S
    Shibata, N
    Takada, K
    Murakami, M
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (09) : 1299 - 1305
  • [9] Pharmacokinetics of Glycyrrhizin in Normal and Albumin-deficient Rats
    Koga, Kenjiro
    Tomoyama, Michiko
    Ohyanagi, Kazuo
    Takada, Kanji
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2008, 29 (07) : 373 - 381
  • [10] Novel formulations of a liver protection drug glycyrrhizin
    Koga, Kenjiro
    Kawashima, Susumu
    Shibata, Nobuhito
    Takada, Kanji
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (07): : 1103 - 1114